How many employees work at Obat?
Obat SAS has approximately 95 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Obat’s total headcount has grown 24.8% from 76 employees in 2023 to 95 in 2026.
Is Obat hiring right now?
Yes, Obat is actively hiring. Obat had 3 active job postings in 2026, a 80.0% decline from 2025 — see job openings & hiring trends.
About Obat’s Workforce
Obat SAS is an Information Technology Services company that employs 95 people worldwide as of March 2026. It is the 6th-largest by headcount among its peers. Founded in 2019, the company is headquartered in Nantes, France.
Obat's workforce has grown 24.8% from 2023 to 2026, up 7.2% year over year in 2026. Its workforce is concentrated most in Western Europe (83.7%), followed by Southeast Asia (9.9%) and Southern Europe (3.4%).
Obat's functional groups are Finance and Operations (46.5%), Engineering (34.7%), and Sales and Marketing (18.8%), with Sales and Marketing growing fastest (up 14.5%). The average salary is $60,032, ranging from a median of $56,000 in Western Europe to $3,000 in Southeast Asia, up 1.0% year over year in 2026.
Obat's active job postings fell 80.0% in 2026 to 3, with new postings per month cooling from 10 in 2023 to 5 in 2026. Overall employee sentiment is neutral but improving.
Sourced from Revelio Labs workforce data.
- Headquarters
- Nantes, France
- Founded
- 2019
- Industry
- Information Technology Services
- Employees
- 95
- YoY
- +7.2% (+8)
As of March 2026
Obat workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Obat. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsObat Annual Employee Count (2023-2026)
- Obat had 95 employees in 2026, a 7.2% increase (+8) from 2025.
- Obat had 96 employees in 2025, a 4.1% increase (+4) from 2024.
- Obat had 92 employees in 2024, a 7.0% decline (+3) from 2023.
- Obat had 89 employees in 2023, a 8.8% increase (+12) from 2022.
Obat's total workforce has grown from 76 employees in 2023 to 95 in 2026.
Obat SAS quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 95 | +8 | +7.2% |
| 2025 | Q4 | 96 | +4 | +4.1% |
| 2025 | Q3 | 90 | -16 | -6.6% |
| 2025 | Q2 | 88 | -24 | -12.1% |
| 2025 | Q1 | 87 | -14 | -9.6% |
| 2024 | Q4 | 92 | +3 | -7.0% |
| 2024 | Q3 | 106 | +26 | +6.7% |
| 2024 | Q2 | 112 | +36 | +13.9% |
| 2024 | Q1 | 101 | +22 | +9.4% |
| 2023 | Q4 | 89 | +12 | +8.8% |
| 2023 | Q3 | 80 | +3 | +1.2% |
| 2023 | Q2 | 76 | +4 | -4.2% |
See Obat's complete headcount history, including quarterly breakdowns.
Get the DataObat Employee Count by Region (2026)
Western Europe accounts for the largest share of Obat's global workforce with approximately 84% of total employees, followed by Southeast Asia and Southern Europe.
Obat employees by region
| Region | Employees | % of Total |
|---|---|---|
| Western Europe | 71 | 83.7% |
| Southeast Asia | 8 | 9.9% |
| Southern Europe | 3 | 3.4% |
| Sub-Saharan Africa | 1 | 1.6% |
| Northern Europe | 1 | 0.8% |
| North America | 1 | 0.6% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataObat Employee Count by Department (2026)
Obat's employee groups are Finance and Operations (46.5%), Engineering (34.7%), and Sales and Marketing (18.8%).
Obat employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 44 | 46.5% |
| Engineering | 33 | 34.7% |
| Sales and Marketing | 18 | 18.8% |
Compare Obat's department mix to industry peers.
See Full DataObat Employee Salary by Region (2026)
Obat's average employee salary is $60,032 globally. Employees in Western Europe receive the highest compensation. Pay is lowest in Southeast Asia, at a median of $3,000.
Obat median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Western Europe | $56,000 |
| Southern Europe | $43,000 |
| Southeast Asia | $3,000 |
Unlock salary by role, level, and city — and compare to Obat's industry peers.
Unlock Salary DataObat Job Openings and Hiring Trends (2023-2026)
- Obat had 3 active job postings in 2026, a 80.0% decline (-3) from 2025.
- Obat had 6 active job postings in 2025, a 66.7% decline (-6) from 2024.
- Obat had 12 active job postings in 2024, a 85.7% decline (-18) from 2023.
- Obat had 30 active job postings in 2023, a 92.7% increase from 2022.
- Hiring velocity in 2026: 5 new roles/month, up from 4 in 2025 and 5 in 2024.
Obat's hiring is slowing: active job postings fell 80.0% in 2026 to 3, with new postings per month cooling from 10 in 2023 to 5 in 2026.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataObat Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Obat's workforce based on public professional data. Overall sentiment is neutral and has improved year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Information Technology Services Companies by Employee Count
Frequently Asked Questions About Obat
- How fast is Obat growing?
- In 2026, Obat's headcount grew 7.2% to 95 employees, up from 87 in 2025.
- See the full headcount history
- Where are Obat employees located?
- Most Obat employees are based in Western Europe (83.7% of headcount), followed by Southeast Asia and Southern Europe.
- Explore where the workforce is based
- What is the average salary at Obat?
- The average employee salary at Obat is approximately $60k per year.
- Analyze the salary distribution
- How many new job postings does Obat open per year?
- In Q1 2026, Obat opened 14 new job postings. In 2025, Obat opened 50 new job postings — about 4 per month.
- Track hiring trends by role
- When was Obat founded and where is it headquartered?
- Obat was founded in 2019 and is headquartered in Nantes, France.
- Compare Obat to industry peers
Speak with a workforce expert about Obat.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.